Differentially expressed genes associated with cis-Diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and cDNA microarray

Head and Neck

Volumn 25, Issue 3, 2003, Pages 187-193

  Higuchi, Eisaku ^a   Oridate, Nobuhik ^a   Furuta, Yasushi ^a   Suzuki, Seigo ^a   Hatakeyama, Hiromitsu ^a   Sawa, Hirofumi ^a   Sunayashiki Kusuzaki, Kousaku ^b   Yamazaki, Ken ichi ^b   Inuyama, Yukio ^a   Fukuda, Satoshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

CDDP resistance; CDNA microarray; Differential display; Head and neck squamous cell carcinoma

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA;

ARTICLE; CANCER CHEMOTHERAPY; CELL SURVIVAL; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DNA MICROARRAY; DOWN REGULATION; DRUG SENSITIVITY; FLUORESCENCE; GENE CONTROL; GENE EXPRESSION; GENETIC CODE; HEAD CANCER; HUMAN; HUMAN CELL; NECK CANCER; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UPREGULATION;

BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; CISPLATIN; DNA, COMPLEMENTARY; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETIC MARKERS; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHARMACOGENETICS; PHENOTYPE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037372654     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10204     Document Type: Article

References (17)

1. Meijer C, Mulder NH, de Vries EG. The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin. Cancer Treat Rev 1990;17:389-407.
2. Kasahara K, Fujiwara Y, Nishio K, et al. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 1991;51:3237-3242.
3. Teicher BA, Holden SA, Kelley MJ, et al. Characterization of a human squamous carcinoma cell line resistant to cisdiamminedichloroplatinum (II). Cancer Res 1987;47:388-393.
4. Taniguchi K, Wada M, Kohno K, et al. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 1996;56:4124-4129.
5. Kraker AJ, Moore CW. Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum (II) resistant P388 murine leukemia cell line. Cancer Lett 1988;38:307-314.
6. Chu G, Chang E. Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. Proc Natl Acad Sci USA 1990;87:3324-3328.
7. Liang P, Pardee A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992;257:967-971.
8. Hisano T, Ono M, Nakayama M, Naito S, Kuwano M, Wada M. Increased expression of T-plastin gene in cisplatin-resistant human cancer cells: identification by mRNA differential display. FEBS Lett 1996;397:101-107.
9. Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun 2001;280:1148-1154.
10. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-470.
11. Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990;82:1107-1112.
12. Ito T, Kito K, Adati N, Mitsui Y, Hagiwara H, Sakaki Y. Fluorescent differential display: arbitrarily primed RT-PCR fingerprinting on an automated DNA sequencer. FEBS Lett 1994;351:231-236.
13. McCormick SM, Eskin SG, McIntire LV, et al. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci USA 2001;98:8955-8960.
14. Shen D, Pastan I, Gottesman MM. Cross -resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins. Cancer Res 1998;58:268-275.
15. Marcillac I, Troalen F, Bidart J-M, et al. Free human chorionic gonadotropin β subunit in gonadal and nongonadal neoplasms. Cancer Res 1992;52:3901-3907.
16. Maecker HT, Todd SC, Levy S. The tetraspanin superfamily: molecular facilitators. FASEB J 1997;11:428-442.
17. Marken JS, Schieven GL, Hellström I, Hellström KE, Aruffo A. Cloning and expression of the tumor-associated antigen L6. Proc Natl Acad Sci USA 1992;89:3503-3507.